Haffner Highlights Treatment and Research Considerations for Basal Cell Carcinoma of the Prostate
Dr Haffner explains distinguishing features between basal cell and adenocarcinoma of the prostate, findings from a genomics study of basal cell prostate carcinoma, and the challenges that arise when diagnosing and treating patients with this rare disease.
Michaelc Haffner Ashling Wahner Human Biology Division University Of Washington School Medicine Clinical Research Division Fred Hutch Cancer Center
Source: onclive.com